In The News Posted March 8, 2019 Share Posted March 8, 2019 DUBLIN, Calif., March 7, 2019 /PRNewswire/ -- ZEISS Medical Technology Segment of ZEISS announced that it has received 510(k) clearance from the FDA for the CIRRUS HD-OCT platform, expanding the capabilities of its Anterior Segment Premier Module to include Epithelial Thickness Mapping... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.